Yahoo Web Search

Search results

1. The Allstate Corporation

   NYSE: ALL-PH

   21.55

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.25 (-1.15%)

   At close: Wed. May 29, 2024 3:59 PM EDT · Delayed Quote (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	21.61
     High	21.78
     Low	21.39

   • Mkt Cap	34.66B
     P/E (TTM)	1.79
     Div & Yield	1.28 & 5.92%

   • Prev. Close	21.80
     52 Wk. Low	18.38
     52 Wk. High	24.44

   More about ALL-PH

   Related stocks

   • MET-PE
     MetLife, Inc.
     MET-PE
     23.73
     -0.16%
   • HIG-PG
     The Hartford Financial Services Group, Inc.
     HIG-PG
     24.75
     -0.21%
   • MS-PK
     Morgan Stanley
     MS-PK
     24.40
     -0.81%
   • GS-PK
     The Goldman Sachs Group, Inc.
     GS-PK
     25.03
     -0.04%
   • SCHW-PD
     The Charles Schwab Corporation
     SCHW-PD
     25.03
     -0.36%

   More on Yahoo Finance

2. www.lls.org › treatment › ph-positive-all-therapyPh-Positive ALL Therapy - Leukemia & Lymphoma Society

   www.lls.org › treatment › ph-positive-all-therapy

   • Cached

   About 25 percent of adults with ALL have a subtype called “Ph-positive ALL” (also known as “Ph+ ALL” or “Philadelphia chromosome-positive ALL”). The leukemia cells of these patients have the Philadelphia chromosome, which is formed by a translocation between parts of chromosomes 9 and 22.

3. finance.yahoo.com › quote › ALL-PHThe Allstate Corporation (ALL-PH) Stock Price, News, Quote ...

   finance.yahoo.com › quote › ALL-PH

   • Cached

   24.31. +0.62%. Find the latest The Allstate Corporation (ALL-PH) stock quote, history, news and other vital information to help you with your stock trading and investing.

4. www.nejm.org › doi › fullPhiladelphia Chromosome–Positive Acute Lymphoblastic Leukemia

   www.nejm.org › doi › full

   Jun 22, 2022 · The Philadelphia chromosome (Ph) was the first cytogenetic abnormality associated with a human cancer, chronic myeloid leukemia (CML). 1 The rearrangement between chromosome 9 and chromosome...

5. ashpublications.org › hematology › articlePh+ ALL in 2022: is there an optimal approach? | Hematology ...

   ashpublications.org › hematology › article

   • Cached

   Dec 9, 2022 · Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL) carried a very poor prognosis prior to the advent of tyrosine kinase inhibitors (TKIs) that block the activity of the BCR-ABL1 oncoprotein. With improvements in TKI efficacy and allogeneic hematopoietic cell transplantation (HCT), survival has improved over the past 3 ...

6. ashpublications.org › blood › articlePhiladelphia chromosome–like acute lymphoblastic leukemia

   ashpublications.org › blood › article

   • Cached

   Nov 9, 2017 · Philadelphia chromosome (Ph)-like acute lymphoblastic leukemia (ALL), also referred to as BCR - ABL1 –like ALL, is a high-risk subset with a gene expression profile that shares significant overlap with that of Ph-positive (Ph +) ALL and is suggestive of activated kinase signaling.

   • Author: Sarah K. Tasian, Sarah K. Tasian, Mignon L. Loh, Mignon L. Loh, Stephen P. Hunger, Stephen P. Hunger

   • Publish Year: 2017

7. www.healthline.com › philadelphia-chromosome-allWhat You Need to Know about Philadelphia Chromosome ALL

   www.healthline.com › philadelphia-chromosome-all

   • Cached

   Jan 10, 2022 · Definition. Ph-positive vs. Ph-negative. Getting tested. Risk factors. Treatment. Outlook. Acute lymphocytic leukemia (ALL) is one of the four main types of leukemia. “Acute” means...

8. www.ncbi.nlm.nih.gov › pmc › articlesPhiladelphia-Positive Acute Lymphoblastic Leukemia: Current ...

   www.ncbi.nlm.nih.gov › pmc › articles

   The Philadelphia chromosome (Ph), t(9;22), is seen in about 20 % to 30 % of adults diagnosed with acute lymphoblastic leukemia (ALL). It has been associated with poorer prognosis compared with Ph-negative ALL.